Acadia Healthcare (ACHC) PT Raised to $90 at UBS on Emerging Substance Abuse Opportunity in the UK
Tweet Send to a Friend
UBS analyst A.J. Rice reiterated a Buy rating and raised his price target on Acadia Healthcare (NASDAQ: ACHC) to $90.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
